Clinical Trial Management Software Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Product ; By Delivery Mode ; By Deployment Mode ; By End Use ; By Region

Description

Global Clinical Trial Management Software (CTMS) Market Size Zooming More Than 2.5X to Cross USD 2.6 Billion by 2029

The global clinical trial management software (CTMS) market is gaining traction because of the increasing complexity of clinical trials and the huge amount of data generated and adoption of modern technologies, such as artificial intelligence, in CTMS.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global clinical trial management software (CTMS) market size at USD 1,032.78 million in 2022. During the forecast period between 2023 and 2029, the global clinical trial management software (CTMS) market size is projected to grow at an impressive CAGR of 14.55% reaching a value of USD 2,656.43 million by 2029. Major growth factors for the global clinical trial management software (CTMS) market include the rise in industry-academic partnerships, the rise in clinical trials, the development of healthcare technology, and the expansion of government funding for research trials. Additionally, variables like the rising frequency of chronic diseases have been linked to the growth in the number of clinical trial management systems (CTMS).

Global Clinical Trial Management Software (CTMS) Market - Overview:

An enterprise software system called a clinical trial management system (CTMS) is used to coordinate and monitor clinical research operations within a facility. This system serves various purposes including giving easy access to a summary of a study's development with ongoing and current reporting, enabling research supervisors to schedule assignments and activities, assign roles, measure progress, arranging all of the data and papers pertinent to the study. A CTMS is used by research sites, site networks, health systems, academic medical centers, and cancer centers to centralize data on procedures, participants, staff, finances, and billing, among other things.

Global Clinical Trial Management Software (CTMS) Market - By Deployment Mode:

Based on deployment Mode, the global clinical trial management system (CTMS) market is segmented into enterprise and on-site. Enterprise deployment holds the larger share of the global clinical trial management system (CTMS) market. The segment growth is mainly attributed to its versatility according to the needs of the researchers and other end users. The capabilities of the clinical trial administration system include documents, spreadsheets, payments, contacts, and others. Enterprise-based clinical trial management software provides SMEs and large enterprises with a range of scaling options.

Impact of COVID-19 on the Global Clinical Trial Management Software (CTMS) Market

The global clinical trial management system (CTMS) market witnessed robust growth over the COVID-19 outbreak period. According to a report published on the National Center for Biotechnology Information, the management of clinical studies was adversely affected by the COVID-19 pandemic, which could jeopardize the validity of the data and cause patient safety concerns. It increased the need for efficient management systems, which not only help with the management of ongoing and delayed clinical trial data but also efficiently manage and improve access to clinical trials on the novel corona virus vaccine development.

Competitive Landscape:

Major players operating in the global clinical trial management system (CTMS) market include: Oracle Corporation, Medidata Solutions (a Dassault Systemes Company), Parexel International Corporation, BioClinica, Inc., PRA Health Sciences, Inc., ArisGlobal LLC, Veeva Systems Inc., MedNet Solutions, Inc., Forte Research Systems, Inc., eClinForce, Inc., DSG, Inc., Data MATRIX Corp., Merge Healthcare Incorporated, DATATRAK International, Inc., and MasterControl, Inc.

To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Clinical Trial Management Software (CTMS) market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Clinical Trial Management Software (CTMS) market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Product Code: BWC23421

1. Research Framework

1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation

2. Executive Summary

3. Global Clinical Trial Management Software (CTMS) Market Insights

3.1. Industry Value Chain Analysis
3.2. DROC Analysis
- 3.2.1. Growth Drivers
  - 3.2.1.1. Need for efficient management of trial data and workflows
  - 3.2.1.2. Increasing complexity of clinical trials and the huge amount of data generated
  - 3.2.1.3. The adoption of innovative technologies such as artificial intelligence in CTMS
- 3.2.2. Restraints
  - 3.2.2.1. High implementation and maintenance costs
  - 3.2.2.2. Data privacy and security concerns
- 3.2.3. Opportunities
  - 3.2.3.1. Growing demand for personalized medicine
  - 3.2.3.2. Increasing focus on rare diseases
- 3.2.4. Challenges
  - 3.2.4.1. Ensuring data privacy and security in cloud-based Clinical Trial Management Software (CTMS) systems
3.3. Technology Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter's Five Forces Analysis
- 3.5.1. Bargaining Power of Suppliers
- 3.5.2. Bargaining Power of Buyers
- 3.5.3. Threat of New Entrants
- 3.5.4. Threat of Substitutes
- 3.5.5. Intensity of Rivalry

4. Global Clinical Trial Management Software (CTMS) Market Overview

4.1. Market Size & Forecast, 2019-2029
- 4.1.1. By Value (USD Million)
4.2. Market Share and Forecast
- 4.2.1. By Product
  - 4.2.1.1. Software
  - 4.2.1.2. Services
- 4.2.2. By Delivery
  - 4.2.2.1. Web-hosted
  - 4.2.2.2. On-premises
  - 4.2.2.3. Cloud-based
- 4.2.3. By Deployment Mode
  - 4.2.3.1. Enterprise
  - 4.2.3.2. On-site
- 4.2.4. By End Use
  - 4.2.4.1. Pharma
  - 4.2.4.2. Medical Device Manufacturers
  - 4.2.4.3. CROs
  - 4.2.4.4. Others
- 4.2.5. By Region
  - 4.2.5.1. North America
  - 4.2.5.2. Europe
  - 4.2.5.3. Asia Pacific (APAC)
  - 4.2.5.4. Latin America (LATAM)
  - 4.2.5.5. Middle East and Africa (MEA)

5. North America Clinical Trial Management Software (CTMS) Market

5.1. Market Size & Forecast, 2019-2029
- 5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
- 5.2.1. By Product
- 5.2.2. By Delivery
- 5.2.3. By Deployment Mode
- 5.2.4. By End Use
- 5.2.5. By Country
  - 5.2.5.1. United States
  - 5.2.5.1.1. By Product
  - 5.2.5.1.2. By Delivery
  - 5.2.5.1.3. By Deployment Mode
  - 5.2.5.1.4. By End Use
  - 5.2.5.2. Canada
  - 5.2.5.2.1. By Product
  - 5.2.5.2.2. By Delivery
  - 5.2.5.2.3. By Deployment Mode
  - 5.2.5.2.4. By End Use

6. Europe Clinical Trial Management Software (CTMS) Market

6.1. Market Size & Forecast, 2019-2029
- 6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By Delivery
- 6.2.3. By Deployment Mode
- 6.2.4. By End Use
- 6.2.5. By Country
  - 6.2.5.1. Germany
  - 6.2.5.1.1. By Product
  - 6.2.5.1.2. By Delivery
  - 6.2.5.1.3. By Deployment Mode
  - 6.2.5.1.4. By End Use
  - 6.2.5.2. United Kingdom
  - 6.2.5.2.1. By Product
  - 6.2.5.2.2. By Delivery
  - 6.2.5.2.3. By Deployment Mode
  - 6.2.5.2.4. By End Use
  - 6.2.5.3. Italy
  - 6.2.5.3.1. By Product
  - 6.2.5.3.2. By Delivery
  - 6.2.5.3.3. By Deployment Mode
  - 6.2.5.3.4. By End Use
  - 6.2.5.4. France
  - 6.2.5.4.1. By Product
  - 6.2.5.4.2. By Delivery
  - 6.2.5.4.3. By Deployment Mode
  - 6.2.5.4.4. By End Use
  - 6.2.5.5. Spain
  - 6.2.5.5.1. By Product
  - 6.2.5.5.2. By Delivery
  - 6.2.5.5.3. By Deployment Mode
  - 6.2.5.5.4. By End Use
  - 6.2.5.6. Belgium
  - 6.2.5.6.1. By Product
  - 6.2.5.6.2. By Delivery
  - 6.2.5.6.3. By Deployment Mode
  - 6.2.5.6.4. By End Use
  - 6.2.5.7. Russia
  - 6.2.5.7.1. By Product
  - 6.2.5.7.2. By Delivery
  - 6.2.5.7.3. By Deployment Mode
  - 6.2.5.7.4. By End Use
  - 6.2.5.8. The Netherlands
  - 6.2.5.8.1. By Product
  - 6.2.5.8.2. By Delivery
  - 6.2.5.8.3. By Deployment Mode
  - 6.2.5.8.4. By End Use
  - 6.2.5.9. Rest of Europe
  - 6.2.5.9.1. By Product
  - 6.2.5.9.2. By Delivery
  - 6.2.5.9.3. By Deployment Mode
  - 6.2.5.9.4. By End Use

7. Asia-Pacific Clinical Trial Management Software (CTMS) Market

7.1. Market Size & Forecast, 2019-2029
- 7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Delivery
- 7.2.3. By Deployment Mode
- 7.2.4. By End Use
- 7.2.5. By Country
  - 7.2.5.1. China
  - 7.2.5.1.1. By Product
  - 7.2.5.1.2. By Delivery
  - 7.2.5.1.3. By Deployment Mode
  - 7.2.5.1.4. By End Use
  - 7.2.5.2. India
  - 7.2.5.2.1. By Product
  - 7.2.5.2.2. By Delivery
  - 7.2.5.2.3. By Deployment Mode
  - 7.2.5.2.4. By End Use
  - 7.2.5.3. Japan
  - 7.2.5.3.1. By Product
  - 7.2.5.3.2. By Delivery
  - 7.2.5.3.3. By Deployment Mode
  - 7.2.5.3.4. By End Use
  - 7.2.5.4. South Korea
  - 7.2.5.4.1. By Product
  - 7.2.5.4.2. By Delivery
  - 7.2.5.4.3. By Deployment Mode
  - 7.2.5.4.4. By End Use
  - 7.2.5.5. Australia & New Zealand
  - 7.2.5.5.1. By Product
  - 7.2.5.5.2. By Delivery
  - 7.2.5.5.3. By Deployment Mode
  - 7.2.5.5.4. By End Use
  - 7.2.5.6. Indonesia
  - 7.2.5.6.1. By Product
  - 7.2.5.6.2. By Delivery
  - 7.2.5.6.3. By Deployment Mode
  - 7.2.5.6.4. By End Use
  - 7.2.5.7. Malaysia
  - 7.2.5.7.1. By Product
  - 7.2.5.7.2. By Delivery
  - 7.2.5.7.3. By Deployment Mode
  - 7.2.5.7.4. By End Use
  - 7.2.5.8. Singapore
  - 7.2.5.8.1. By Product
  - 7.2.5.8.2. By Delivery
  - 7.2.5.8.3. By Deployment Mode
  - 7.2.5.8.4. By End Use
  - 7.2.5.9. Vietnam
  - 7.2.5.9.1. By Product
  - 7.2.5.9.2. By Delivery
  - 7.2.5.9.3. By Deployment Mode
  - 7.2.5.9.4. By End Use
  - 7.2.5.10. Rest of APAC
  - 7.2.5.10.1. By Product
  - 7.2.5.10.2. By Delivery
  - 7.2.5.10.3. By Deployment Mode
  - 7.2.5.10.4. By End Use

8. Latin America Clinical Trial Management Software (CTMS) Market

8.1. Market Size & Forecast, 2019-2029
- 8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Delivery
- 8.2.3. By Deployment Mode
- 8.2.4. By End Use
- 8.2.5. By Country
  - 8.2.5.1. Brazil
  - 8.2.5.1.1. By Product
  - 8.2.5.1.2. By Delivery
  - 8.2.5.1.3. By Deployment Mode
  - 8.2.5.1.4. By End Use
  - 8.2.5.2. Mexico
  - 8.2.5.2.1. By Product
  - 8.2.5.2.2. By Delivery
  - 8.2.5.2.3. By Deployment Mode
  - 8.2.5.2.4. By End Use
  - 8.2.5.3. Argentina
  - 8.2.5.3.1. By Product
  - 8.2.5.3.2. By Delivery
  - 8.2.5.3.3. By Deployment Mode
  - 8.2.5.3.4. By End Use
  - 8.2.5.4. Peru
  - 8.2.5.4.1. By Product
  - 8.2.5.4.2. By Delivery
  - 8.2.5.4.3. By Deployment Mode
  - 8.2.5.4.4. By End Use
  - 8.2.5.5. Rest of LATAM
  - 8.2.5.5.1. By Product
  - 8.2.5.5.2. By Delivery
  - 8.2.5.5.3. By Deployment Mode
  - 8.2.5.5.4. By End Use

9. Middle East & Africa Clinical Trial Management Software (CTMS) Market

9.1. Market Size & Forecast, 2019-2029
- 9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Delivery
- 9.2.3. By Deployment Mode
- 9.2.4. By End Use
- 9.2.5. By Country
  - 9.2.5.1. Saudi Arabia
  - 9.2.5.1.1. By Product
  - 9.2.5.1.2. By Delivery
  - 9.2.5.1.3. By Deployment Mode
  - 9.2.5.1.4. By End Use
  - 9.2.5.2. UAE
  - 9.2.5.2.1. By Product
  - 9.2.5.2.2. By Delivery
  - 9.2.5.2.3. By Deployment Mode
  - 9.2.5.2.4. By End Use
  - 9.2.5.3. Qatar
  - 9.2.5.3.1. By Product
  - 9.2.5.3.2. By Delivery
  - 9.2.5.3.3. By Deployment Mode
  - 9.2.5.3.4. By End Use
  - 9.2.5.4. Kuwait
  - 9.2.5.4.1. By Product
  - 9.2.5.4.2. By Delivery
  - 9.2.5.4.3. By Deployment Mode
  - 9.2.5.4.4. By End Use
  - 9.2.5.5. South Africa
  - 9.2.5.5.1. By Product
  - 9.2.5.5.2. By Delivery
  - 9.2.5.5.3. By Deployment Mode
  - 9.2.5.5.4. By End Use
  - 9.2.5.6. Nigeria
  - 9.2.5.6.1. By Product
  - 9.2.5.6.2. By Delivery
  - 9.2.5.6.3. By Deployment Mode
  - 9.2.5.6.4. By End Use
  - 9.2.5.7. Algeria
  - 9.2.5.7.1. By Product
  - 9.2.5.7.2. By Delivery
  - 9.2.5.7.3. By Deployment Mode
  - 9.2.5.7.4. By End Use
  - 9.2.5.8. Rest of MEA
  - 9.2.5.8.1. By Product
  - 9.2.5.8.2. By Delivery
  - 9.2.5.8.3. By Deployment Mode
  - 9.2.5.8.4. By End Use

10. Competitive Landscape

10.1. List of Key Players and Their Offerings
10.2. Global Clinical Trial Management Software (CTMS) Market Share Analysis, 2022
10.3. Competitive Benchmarking, By Operating Parameters
10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Clinical Trial Management Software (CTMS) Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

12.1. Oracle Corporation
12.2. Medidata Solutions (a Dassault Systemes Company)
12.3. Parexel International Corporation
12.4. BioClinica, Inc.
12.5. PRA Health Sciences, Inc.
12.6. ArisGlobal LLC
12.7. Veeva Systems Inc.
12.8. MedNet Solutions, Inc.
12.9. Forte Research Systems, Inc.
12.10. eClinForce, Inc.
12.11. DSG, Inc.
12.12. Data MATRIX Corp.
12.13. Merge Healthcare Incorporated
12.14. DATATRAK International, Inc.
12.15. MasterControl, Inc.
12.16. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

14.1. Qualitative Research
- 14.1.1. Primary & Secondary Research
14.2. Quantitative Research
14.3. Market Breakdown & Data Triangulation
- 14.3.1. Secondary Research
- 14.3.2. Primary Research
14.4. Breakdown of Primary Research Respondents, By Region
14.5. Assumptions & Limitations